Loss of DUSP5 did not influence the mechanism of carcinogenesis as 90% of the DUSP5−/− papillomas contained the signature HrasQ61L mutation, nor was tumour morphology or size affected by DUSP5 deletion. The gene discussed is DUSP5; the disease is neoplasm.